We are live on ! Find out more
CD

Christopher Davis Davis Selected Advisers

AUM $23.3B
1-Year Est. Return 26.95%
 

Christopher Davis is chairman of Davis Advisors, a multi-generational investment firm known for research-intensive equity management. The firm’s strategies often emphasize financials and other businesses where long-term ownership and careful accounting analysis matter. Davis is a frequent public commentator on active management and long-horizon investing.

This Fund
S&P 500
This Quarter Est. Return
+3.91%
1 Year Est. Return
+26.95%
3 Year Est. Return
+93.11%
5 Year Est. Return
+96.73%
10 Year Est. Return
+388.76%
AUM
$22.9B
AUM Growth
-$331M
Cap. Flow
-$1.06B
Cap. Flow %
-4.63%
Top 10 Hldgs %
47.88%
Holding
146
New
5
Increased
59
Reduced
74
Closed
4

Top Sells

Rank Stock Value
1
MON
Monsanto Co
MON
+$550M
2
AMZN icon
Amazon
AMZN
+$169M
3
JPM icon
JPMorgan Chase
JPM
+$152M
4
V icon
Visa
V
+$95.4M
5
UNH icon
UnitedHealth
UNH
+$66.7M

Sector Composition

Rank Sector Weight
1 Financials 38.79%
2 Consumer Discretionary 13.4%
3 Communication Services 12.27%
4 Energy 10.41%
5 Industrials 9.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SITC icon
126
SITE Centers
SITC
$161M
$1.69M 0.01%
144,830
-18
-0% -$235
CHUBA
127
DELISTED
CommerceHub, Inc. Series A Common Stock
CHUBA
$1.6M 0.01%
92,061
-10,060
-10% -$166K
WUBA
128
DELISTED
58.com Inc
WUBA
$1.34M 0.01%
30,336
+1,190
+4% +$49K
INTC icon
129
Intel
INTC
$476B
$1.2M 0.01%
35,596
+9,390
+36% +$336K
HAPN
130
Happen Inc
HAPN
$2.13B
$1.03M ﹤0.01%
37,580
-14,400
-28% -$409K
DD icon
131
DuPont de Nemours
DD
$18.7B
$871K ﹤0.01%
+5,453
New +$866K
PPG icon
132
PPG Industries
PPG
$25.3B
$601K ﹤0.01%
5,470
XLNX
133
DELISTED
Xilinx Inc
XLNX
$509K ﹤0.01%
7,920
LRCX icon
134
Lam Research
LRCX
$393B
$493K ﹤0.01%
34,850
-8,700
-20% -$128K
DXC icon
135
DXC Technology
DXC
$1.73B
$473K ﹤0.01%
+7,120
New +$473K
MU icon
136
Micron Technology
MU
$1.09T
$383K ﹤0.01%
12,828
-3,200
-20% -$93.6K
HPQ icon
137
HP
HPQ
$27.2B
$364K ﹤0.01%
20,830
BBU
138
DELISTED
Brookfield Business Partners
BBU
$360K ﹤0.01%
20,732
HPE icon
139
Hewlett Packard
HPE
$70.8B
$346K ﹤0.01%
26,850
-8,989
-25% -$125K
APD icon
140
Air Products & Chemicals
APD
$67.9B
$266K ﹤0.01%
1,860
+12
+0.6% +$1.71K
JMEI
141
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$225K ﹤0.01%
10,549
+364
+4% +$11.1K
PCAR icon
142
PACCAR
PCAR
$69B
$208K ﹤0.01%
4,716
+18
+0.4% +$778
BHC icon
143
Bausch Health
BHC
$2.41B
-3,917,812
Closed -$43.2M
NYRT
144
DELISTED
New York REIT, Inc.
NYRT
-63,520
Closed -$6.16M
DFT
145
DELISTED
DuPont Fabros Technology Inc.
DFT
-168,810
Closed -$8.37M
MBLY
146
DELISTED
Mobileye N.V.
MBLY
-573,570
Closed -$35.2M

Similar funds

Christopher Davis's Q2 2017 Portfolio in Review

As of Q2 2017, Christopher Davis held 146 positions worth $22.9B, down 1.4% from $23.2B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Christopher Davis withdrew a net $1.06B in Q2 2017, closing 4 positions and reducing 74 holdings. Its most notable exit was Bausch Health, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 39% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Christopher Davis opened a new position in Alleghany Corp worth $46.4M.

  • Christopher Davis's largest Q2 2017 buy was Alleghany Corp: 77,974 shares worth $46.4M.
  • Christopher Davis added most to Capital One in Q2 2017, an estimated $347M increase.
  • Christopher Davis's biggest Q2 2017 reduction was Monsanto Co, cutting an estimated $550M.
  • Christopher Davis fully exited Bausch Health in Q2 2017, selling an estimated $43.2M.
  • Christopher Davis's ten largest holdings make up 48% of its $22.9B portfolio in Q2 2017.
  • Christopher Davis opened 5 new positions and closed 4 in Q2 2017.
  • Christopher Davis's portfolio value fell 1.4% quarter-over-quarter to $22.9B.

Based on Davis Selected Advisers's 13F filing for Q2 2017, filed 9 Aug 2017.